Yoshikazu Yamamoto Selected Research

Infections

1/2014	Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenza.
4/2005	[Sepsis and blood culture management].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshikazu Yamamoto Research Topics

Disease

3	Neoplasms (Cancer) 01/2017 - 11/2009
2	Infections 01/2014 - 04/2005
1	Hepatocellular Carcinoma (Hepatoma) 11/2020
1	Gaucher Disease (Gaucher's Disease) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Pain (Aches) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Anemia 01/2020
1	Immunoglobulin G4-Related Disease 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2019
1	Lymphadenopathy 01/2019
1	Castleman Disease (Castleman's Disease) 01/2019
1	Enteropathy-Associated T-Cell Lymphoma 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Disease Progression 01/2018
1	Hemophilia A (Haemophilia) 11/2015
1	Evans Syndrome 11/2015
1	Thrombotic Thrombocytopenic Purpura 11/2015
1	Fever (Fevers) 01/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2015
1	Vasculitis (Vasculitides) 01/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2014
1	Human Influenza (Influenza) 01/2014
1	Cytokine Release Syndrome 01/2014
1	Chylous Ascites 10/2013
1	Body Weight (Weight, Body) 04/2010
1	Leukemia 11/2009
1	Neoplasm Metastasis (Metastasis) 03/2009
1	Adenosquamous Carcinoma 03/2009
1	Heart Failure 11/2008
1	Renal Insufficiency (Renal Failure) 04/2005
1	Bacteremia 04/2005

Drug/Important Bio-Agent (IBA)

3	Prednisolone (Predate)FDA LinkGeneric 01/2019 - 10/2013
3	Rituximab (Mabthera)FDA Link 01/2017 - 10/2013
2	Indicators and Reagents (Reagents)IBA 07/2013 - 11/2008
1	Warfarin (Coumadin)FDA LinkGeneric 11/2020
1	acarboxyprothrombin (PIVKA)IBA 11/2020
1	Vitamin K FDA Link 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	InterleukinsIBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	thiamine triphosphorate (TTP)IBA 11/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2015
1	Azacitidine (5 Azacytidine)FDA Link 01/2015
1	Imatinib Mesylate (Gleevec)FDA Link 03/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	diisopropylamine dichloroacetate (DIPA)IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	CytokinesIBA 01/2014
1	pyruvate dehydrogenase kinase 4IBA 01/2014
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2014
1	TrypsinIBA 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2013
1	Vincristine (Oncovin)FDA LinkGeneric 10/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2013
1	Hormones (Hormone)IBA 07/2013
1	bis(tri-n-butyltin)oxide (tributyltin oxide)IBA 04/2010
1	16-O-acetyl-leucotylic acidIBA 11/2009
1	AcidsIBA 11/2009
1	AcetoneIBA 11/2009
1	Betulinic AcidIBA 11/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2009
1	Carcinoembryonic AntigenIBA 03/2009
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2005
1	Anti-Infective Agents (Microbicides)IBA 04/2005
1	Pharmaceutical PreparationsIBA 04/2005

Therapy/Procedure

6	Therapeutics 01/2018 - 04/2005
1	Enzyme Replacement Therapy 01/2020
1	Splenectomy 01/2020
1	Salvage Therapy 01/2018
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2018
1	Gastrectomy 03/2014
1	Oral Administration 01/2014
1	Drug Therapy (Chemotherapy) 03/2009